ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 985,82
0,09%
Dow Jones
38 122,49
0,03%
DAX
18 506,73
-0,04%
Brent Oil
81,685
-0,32%
Bitcoin
67 821,59
-0,79%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Chimerix Inc (CMRX)

  7. Chimerix Inc (CMRX) Actualités

CMRX

Chimerix (CMRX)

Chimerix Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:CMRX
DateHeureSourceTitreSymboleSociété
30/05/202413h00GlobeNewswire Inc.Chimerix to Participate in Fireside Chat at Jefferies Global Healthcare ConferenceNASDAQ:CMRXChimerix Inc
06/05/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CMRXChimerix Inc
01/05/202413h00GlobeNewswire Inc.Chimerix Reports First Quarter 2024 Financial Results and Provides Operational UpdateNASDAQ:CMRXChimerix Inc
24/04/202413h00GlobeNewswire Inc.Chimerix to Report First Quarter 2024 Financial Results and Provide an Operational Update on May 1, 2024NASDAQ:CMRXChimerix Inc
16/04/202422h05GlobeNewswire Inc.Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:CMRXChimerix Inc
21/03/202412h00GlobeNewswire Inc.Chimerix Appoints Marc D. Kozin to Board of DirectorsNASDAQ:CMRXChimerix Inc
29/02/202415h20Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CMRXChimerix Inc
29/02/202414h24Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:CMRXChimerix Inc
29/02/202413h58Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CMRXChimerix Inc
29/02/202413h00GlobeNewswire Inc.Chimerix Reports Fourth Quarter and Year End 2023 Financial Results and Provides Operational UpdateNASDAQ:CMRXChimerix Inc
27/02/202413h00GlobeNewswire Inc.Chimerix to Present at TD Cowen 44th Annual Health Care ConferenceNASDAQ:CMRXChimerix Inc
22/02/202413h00GlobeNewswire Inc.Chimerix to Report Fourth Quarter and Year End 2023 Financial Results and Provide an Operational Update on February 29, 2024NASDAQ:CMRXChimerix Inc
17/02/202402h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CMRXChimerix Inc
14/02/202423h01Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CMRXChimerix Inc
14/02/202419h28Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CMRXChimerix Inc
02/01/202417h07Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CMRXChimerix Inc
29/12/202313h00GlobeNewswire Inc.Chimerix Appoints Lisa Decker to Board of DirectorsNASDAQ:CMRXChimerix Inc
04/12/202313h00GlobeNewswire Inc.Chimerix Promotes Michelle LaSpaluto to Chief Financial OfficerNASDAQ:CMRXChimerix Inc
24/11/202313h00GlobeNewswire Inc.Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:CMRXChimerix Inc
16/11/202313h00GlobeNewswire Inc.Chimerix Strengthens Executive Leadership Team with Appointment of Thomas Riga as Chief Operating and Commercial OfficerNASDAQ:CMRXChimerix Inc
02/11/202313h22Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CMRXChimerix Inc
02/11/202312h00GlobeNewswire Inc.Chimerix Reports Third Quarter 2023 Financial Results and Provides Operational UpdateNASDAQ:CMRXChimerix Inc
26/10/202313h00GlobeNewswire Inc.Chimerix to Report Third Quarter 2023 Financial Results and Provide an Operational Update on November 2, 2023NASDAQ:CMRXChimerix Inc
29/09/202322h54Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CMRXChimerix Inc
05/09/202313h00GlobeNewswire Inc.Chimerix to Participate in Upcoming Investor ConferencesNASDAQ:CMRXChimerix Inc
16/08/202316h05GlobeNewswire Inc.Chimerix Announces Data Highlighting Clinical Efficacy and Molecular Mechanisms of Response to ONC201 Treatment of H3 K27M-Mutant Diffuse Midline Gliomas Published in "Cancer Discovery"NASDAQ:CMRXChimerix Inc
03/08/202313h00GlobeNewswire Inc.Chimerix Reports Second Quarter 2023 Financial Results and Provides Operational UpdateNASDAQ:CMRXChimerix Inc
27/07/202313h00GlobeNewswire Inc.Chimerix to Report Second Quarter 2023 Financial Results and Provide an Operational Update on August 3, 2023NASDAQ:CMRXChimerix Inc
27/06/202322h31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CMRXChimerix Inc
27/06/202322h05GlobeNewswire Inc.Chimerix Announces Promotion of Michael T. Andriole to President and Chief Executive OfficerNASDAQ:CMRXChimerix Inc
 Showing the most relevant articles for your search:NASDAQ:CMRX

Dernières Valeurs Consultées

EU
0003U
0003U
NASDAQ
CCAI
Cascadia Acquisition
EU
SSBOD
Euronext S Bouygues 0303...
TG
MFZ
Mitsubishi UFJ Financial
BIT
P1Y664
NLBNPIT1Y664 20240920 3
USOTC
JDLGY
JD Logistics (PK)
NYSE
JGH
Nuveen Global High Income
ASX
HRZ
Horizon Minerals
BOV
MWET4Q
WETZEL PN
LSE
ELE
NEO
AMZN
Amazoncom CDR CAD Hedged
BOV
PORT3Q
Wilson Sons Holdings Bra... ON
EU
ALPRG
Prologue
EU
ALORD
Ordissimo
BOV
WEST3R
Westwing Comercio Vareji... ON
EU
E605T
E605T
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés